Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-FANCA Antibody (R1D81)

Catalog #:   RHA50301 Specific References (26) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IP, WB
Accession: O15360
Overview

Catalog No.

RHA50301

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IP: 1:20-1:50, WB: 1:1000-1:2000

Target

FAA, FANCA, FANCH, Fanconi anemia group A protein, Protein FACA, FACA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O15360

Applications

IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1D81

Data Image
  • Western blot
    Western blot analysis of FANCA expression in A431 cell lysate.
References

Case Report: Complete response to four cycles of camrelizumab in a PD-L1 negative patient with advanced oral squamous cancer., PMID:40066447

[Homozygous Variant of FANCM of the Fanconi Anemia Pathway Causes Premature Ovarian Insufficiency: Investigation of the Pathogenic Mechanism]., PMID:38948269

Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice., PMID:38447038

Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing., PMID:37934348

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer., PMID:37336919

Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report., PMID:33345750

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment., PMID:32778095

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors., PMID:32554069

Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning., PMID:32226796

A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families., PMID:29098742

Common Variable Immunodeficiency Caused by FANC Mutations., PMID:28493158

V(D)J recombination process and the Pre-B to immature B-cells transition are altered in Fanca-/- mice., PMID:27883081

Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients - A Mere Coincidence?, PMID:26106590

p38 Mitogen-activated protein kinase inhibition enhances in vitro erythropoiesis of Fanconi anemia, complementation group A-deficient bone marrow cells., PMID:25534205

Fanca deficiency reduces A/T transitions in somatic hypermutation and alters class switch recombination junctions in mouse B cells., PMID:24799500

Fanconi anemia complementation group A (FANCA) localizes to centrosomes and functions in the maintenance of centrosome integrity., PMID:23806870

FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons., PMID:21414716

Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination., PMID:15601828

Deficient regulation of DNA double-strand break repair in Fanconi anemia fibroblasts., PMID:12748186

Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links., PMID:12571280

Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells., PMID:11750104

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway., PMID:11239454

The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG., PMID:11063725

Posttranscriptional cell cycle-dependent regulation of human FANCC expression., PMID:10845936

Analysis of epitope-tagged forms of the dyskeratosis congenital protein (dyskerin): identification of a nuclear localization signal., PMID:10744426

A deficiency in a 230 kDa DNA repair protein in fanconi anemia complementation group A cells is corrected by the FANCA cDNA., PMID:10469633

Datasheet

Document Download

Anti-FANCA Antibody (R1D81).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-FANCA Antibody (R1D81) [RHA50301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only